表紙:大腸癌:世界の治験レビュー
市場調査レポート
商品コード
146301

大腸癌:世界の治験レビュー

Colon Cancer Global Clinical Trials Review, H1, 2019

出版日: | 発行: GlobalData | ページ情報: 英文 787 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.86円
大腸癌:世界の治験レビュー
出版日: 2019年04月30日
発行: GlobalData
ページ情報: 英文 787 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の主要地域おける大腸癌治療薬の治験数や被験者数、段階別の動向、主要企業や機関、治験のプロファイルなどをまとめています。

イントロダクション

  • 大腸癌
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域上位5ヶ国における治験件数
    • 欧州上位5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:腫瘍の治験件数に対する大腸癌の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:腫瘍の治験件数に対する大腸癌の治験件数比率

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数 大腸癌

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

大腸癌の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース 大腸癌

治験のプロファイル

  • 主要企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Sanofi
    • Pfizer Inc.
    • Novartis AG
    • Amgen Inc.
    • GlaxoSmithKline plc
    • Immunomedics, Inc.
    • Eli Lilly and Company
    • AstraZeneca PLC
  • 代表的な研究機関・病院の治験の概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • The University of Texas M. D. Anderson Cancer Center
    • Stanford University
    • Barbara Ann Karmanos Cancer Institute
    • Mayo Clinic
    • Ohio State University Comprehensive Cancer Center
    • 昭和大学横浜市北部病院
    • Alberta Health Services
    • 大阪消化管がん化学療法研究会

5つの代表的な治験のプロファイル

付録

図表

List of Tables

  • Colon Cancer Therapeutics, Global, Clinical Trials by Region, 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Colon Cancer Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
  • Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2019*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2019*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Colon Cancer Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Colon Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Colon Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
  • Colon Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
  • Colon Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
  • Proportion of Colon Cancer to Oncology Clinical Trials, G7 Countries (%), 2019*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Colon Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Colon Cancer to Oncology Clinical Trials, E7 Countries (%), 2019*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Colon Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Colon Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Colon Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Colon Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • GlobalData Methodology
目次
Product Code: GDHC5595CTIDB

GlobalData's clinical trial report, "Colon Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Clinical Trials by G7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Colon Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Colon Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Colon Cancer
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source